Literature DB >> 24490032

Baclofen in the management of cannabis dependence syndrome.

Bruce Imbert1, Nathalie Labrune2, Christophe Lancon2, Nicolas Simon2.   

Abstract

Cannabis is the most commonly used illicit drug in the world. However, only few studies have shown the efficacy of pharmacologic agents in targeting cannabis withdrawal symptoms or reducing the reinforcing effects of cannabis. Baclofen has been shown to reduce cannabis withdrawal symptoms and the subjective effects of cannabis. We think that the clinical utility of baclofen for cannabis dependence is a reasonable approach. A case report using baclofen is presented and provides preliminary support for the use of baclofen in the management of cannabis dependence.

Entities:  

Keywords:  Cannabis dependence; baclofen; cannabis withdrawal

Year:  2014        PMID： 24490032      PMCID： PMC3896138          DOI： 10.1177/2045125313512324

Source DB:  PubMed          Journal:  Ther Adv Psychopharmacol        ISSN： 2045-1253


  17 in total

1.  Baclofen in cannabis dependence syndrome.

Authors:  Subodh Bhagyalakshmi Nanjayya; Madhusudhan Shivappa; Prabhat Kumar Chand; Pratima Murthy; Vivek Benegal
Journal:  Biol Psychiatry       Date:  2010-05-21       Impact factor: 13.382

Review 2.  The endocannabinoid system as a target for the treatment of cannabis dependence.

Authors:  Jason R Clapper; Regina A Mangieri; Daniele Piomelli
Journal:  Neuropharmacology       Date:  2008-07-19       Impact factor: 5.250

3.  The Cannabis Withdrawal Scale development: patterns and predictors of cannabis withdrawal and distress.

Authors:  David J Allsop; Melissa M Norberg; Jan Copeland; Shanlin Fu; Alan J Budney
Journal:  Drug Alcohol Depend       Date:  2011-07-02       Impact factor: 4.492

4.  Effects of baclofen and mirtazapine on a laboratory model of marijuana withdrawal and relapse.

Authors:  Margaret Haney; Carl L Hart; Suzanne K Vosburg; Sandra D Comer; Stephanie Collins Reed; Ziva D Cooper; Richard W Foltin
Journal:  Psychopharmacology (Berl)       Date:  2010-06-03       Impact factor: 4.530

Review 5.  Baclofen: a new drug for the treatment of alcohol dependence.

Authors:  G Addolorato; L Leggio; R Agabio; G Colombo; G Gasbarrini
Journal:  Int J Clin Pract       Date:  2006-08       Impact factor: 2.503

Review 6.  The cannabis withdrawal syndrome.

Authors:  Alan J Budney; John R Hughes
Journal:  Curr Opin Psychiatry       Date:  2006-05       Impact factor: 4.741

7.  Randomized placebo-controlled trial of baclofen for cocaine dependence: preliminary effects for individuals with chronic patterns of cocaine use.

Authors:  Steven Shoptaw; Xiaowei Yang; Erin J Rotheram-Fuller; Ya-Ching M Hsieh; Prudencia C Kintaudi; V C Charuvastra; Walter Ling
Journal:  J Clin Psychiatry       Date:  2003-12       Impact factor: 4.384

Review 8.  Neurobiological mechanisms of cannabinoid addiction.

Authors:  L Fattore; P Fadda; M S Spano; M Pistis; W Fratta
Journal:  Mol Cell Endocrinol       Date:  2008-02-16       Impact factor: 4.102

9.  Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study.

Authors:  Giovanni Addolorato; Fabio Caputo; Esmeralda Capristo; Marco Domenicali; Mauro Bernardi; Luigi Janiri; Roberta Agabio; Giancarlo Colombo; Gian Luigi Gessa; Giovanni Gasbarrini
Journal:  Alcohol Alcohol       Date:  2002 Sep-Oct       Impact factor: 2.826

Review 10.  Pharmacotherapy for cannabis dependence: how close are we?

Authors:  Ryan Vandrey; Margaret Haney
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749
View more
  4 in total

Review 1.  Are Alcohol Anti-relapsing and Alcohol Withdrawal Drugs Useful in Cannabinoid Users?

Authors:  Patrycja Kleczkowska; Irena Smaga; Małgorzata Filip; Magdalena Bujalska-Zadrozny
Journal:  Neurotox Res       Date:  2016-08-02       Impact factor: 3.911

Review 2.  Pharmacotherapies for cannabis dependence.

Authors:  Kushani Marshall; Linda Gowing; Robert Ali; Bernard Le Foll
Journal:  Cochrane Database Syst Rev       Date:  2014-12-17

3.  Relative effectiveness of N-acetylcysteine and baclofen as anticraving agents in cannabis dependence - A retrospective study with telephonic follow-up.

Authors:  Venkata Lakshmi Narasimha; Lekhansh Shukla; R P S Shyam; Arun Kandasamy; Vivek Benegal
Journal:  Indian J Psychiatry       Date:  2019 May-Jun       Impact factor: 1.759

4.  Assessment of tripartite headache in a case of depression with partial empty sella syndrome.

Authors:  Roshan F Sutar
Journal:  Indian J Psychiatry       Date:  2020-03-17       Impact factor: 1.759
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.